BioRestorative Therapies, Inc. Share Price & Technical Analysis
BRTX · $0.21 (+10.53%)
Healthcare / Biotechnology
$0.21
+10.53%
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from…
Price chart
Seasonality
May has 1 positive and 2 negative years (last 5 years shown)
0% return in May, 5% avg return in past 3 year May month.
-73% return in 2026, 0% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -8% | -82% | 50% | -33% | 0% | – | – | – | – | – | – | – | -73% |
| 25 | 60% | -37% | 20% | 0% | 0% | 0% | -12% | 20% | -21% | 7% | -27% | 9% | 19% |
| 24 | -11% | -22% | 0% | 0% | -14% | 67% | -21% | 7% | 6% | -6% | 0% | -7% | -2% |
| 23 | 7% | -7% | 21% | 18% | 30% | -17% | -36% | -24% | -18% | 11% | 6% | -11% | -19% |
| 22 | -19% | 65% | -7% | -19% | -7% | -25% | 3% | 3% | -3% | -3% | -3% | -7% | -22% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also operates a commercial biocosmeceutical platform. In addition, it provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$5.10M
P/E ratio
—
52W high
$2.04
52W low
$0.16
Volume
15,13,190
Beta
0.20
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is BioRestorative Therapies, Inc. share price today?
- BioRestorative Therapies, Inc. (BRTX) last traded around $0.21 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BRTX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BRTX. Download the app for real-time alerts.
- How can I analyze BioRestorative Therapies, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.